Upregulation of Renal Sodium Transporters in D5 Dopamine Receptor–Deficient Mice
暂无分享,去创建一个
D. Sibley | I. Armando | P. Jose | Xiaoyan Wang | L. Asico | Zhiwei Yang | G. Eisner | J. Jones | Hewang Li | Yingjin Luo | C. Escano | Quansheng Lu
[1] L. Palmer,et al. Surface expression of sodium channels and transporters in rat kidney: effects of dietary sodium. , 2009, American journal of physiology. Renal physiology.
[2] D. Webb,et al. Combined knockout of collecting duct endothelin A and B receptors causes hypertension and sodium retention. , 2008, American journal of physiology. Renal physiology.
[3] M. Sandberg,et al. Effects of dietary salt on renal Na+ transporter subcellular distribution, abundance, and phosphorylation status. , 2008, American journal of physiology. Renal physiology.
[4] V. A. Villar,et al. Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice , 2008, Pediatric Nephrology.
[5] V. A. Villar,et al. Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. , 2008, The Journal of clinical investigation.
[6] L. Nordquist,et al. Trafficking of ENaC subunits in response to acute insulin in mouse kidney. , 2007, American journal of physiology. Renal physiology.
[7] D. Grandy,et al. Angiotensin-II Type 1 Receptor–Mediated Hypertension in D4 Dopamine Receptor–Deficient Mice , 2006, Hypertension.
[8] D. Sibley,et al. Interaction of Angiotensin II Type 1 and D5 Dopamine Receptors in Renal Proximal Tubule Cells , 2005, Hypertension.
[9] Hyung-Suk Kim,et al. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. , 2005, The Journal of clinical investigation.
[10] S. Turban,et al. Long-Term Regulation of ENaC Expression in Kidney by Angiotensin II , 2003, Hypertension.
[11] R. Felder,et al. G&agr;12- and G&agr;13-Protein Subunit Linkage of D5 Dopamine Receptors in the Nephron , 2003 .
[12] D. Sibley,et al. Mice Lacking D5 Dopamine Receptors Have Increased Sympathetic Tone and Are Hypertensive , 2002, The Journal of Neuroscience.
[13] A. Adeyemo,et al. Genome Scan Among Nigerians Linking Blood Pressure to Chromosomes 2, 3, and 19 , 2002, Hypertension.
[14] J. Granger,et al. Mechanisms of pressure natriuresis , 2002, Current hypertension reports.
[15] M. Knepper,et al. Targeted Proteomic Profiling of Renal Na+ Transporter and Channel Abundances in Angiotensin II Type 1a Receptor Knockout Mice , 2002, Hypertension.
[16] R. Cantor,et al. Genome Scan for Blood Pressure in Dutch Dyslipidemic Families Reveals Linkage to a Locus on Chromosome 4p , 2001, Hypertension.
[17] S. Wank,et al. Impaired renal D1-like and D2-like dopamine receptor interaction in the spontaneously hypertensive rat , 2001 .
[18] D. Grandy,et al. Adrenergic and Endothelin B Receptor-Dependent Hypertension in Dopamine Receptor Type-2 Knockout Mice , 2001, Hypertension.
[19] S. Nielsen,et al. The renal thiazide-sensitive Na-Cl cotransporter as mediator of the aldosterone-escape phenomenon. , 2001, The Journal of clinical investigation.
[20] T. Shohat,et al. A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21. , 2000, American journal of human genetics.
[21] R. Carey,et al. Dopamine1 Receptor, Gs&agr;, and Na+-H+ Exchanger Interactions in the Kidney in Hypertension , 2000 .
[22] G. H. Kim,et al. Long-term regulation of renal Na-dependent cotransporters and ENaC: response to altered acid-base intake. , 2000, American journal of physiology. Renal physiology.
[23] T. Coffman,et al. Regulation of sodium balance and blood pressure by the AT(1A) receptor for angiotensin II. , 2000, Hypertension.
[24] J. Wade,et al. Aldosterone-mediated regulation of ENaC α, β, and γ subunit proteins in rat kidney , 1999 .
[25] A. Cravchik,et al. Functional analysis of the human D5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities. , 1999, Pharmacogenetics.
[26] Gnana Bharathy,et al. The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[27] D. Mattson,et al. Chronic sodium balance and blood pressure response to captopril in conscious mice. , 1998, Hypertension.
[28] R. Felder,et al. Renal dopamine receptors in health and hypertension. , 1998, Pharmacology & therapeutics.
[29] M. Lokhandwala,et al. Renal dopamine receptor function in hypertension. , 1998, Hypertension.
[30] P. Fernández-Llama,et al. Concentrating defect in experimental nephrotic syndrone: altered expression of aquaporins and thick ascending limb Na+ transporters. , 1998, Kidney international.
[31] M. Caron,et al. Silencing of the Constitutive Activity of the Dopamine D1B Receptor , 1996, The Journal of Biological Chemistry.
[32] J. Vane,et al. Roles of endothelin receptors in the regional and systemic vascular responses to ET‐1 in the anaesthetized ganglion‐blocked rat: use of selective antagonists , 1995, British journal of pharmacology.
[33] F. Macciardi,et al. Association of the α-Adducin Locus With Essential Hypertension , 1995 .
[34] D. Grandy,et al. Chromosomal localization of three human D5 dopamine receptor genes. , 1992, Genomics.
[35] D. Sibley,et al. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.
[36] G A Churchill,et al. Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. , 2001, Genomics.
[37] X. X. Li,et al. Dopamine(1) receptor, G(salpha), and Na(+)-H(+) exchanger interactions in the kidney in hypertension. , 2000, Hypertension.
[38] D. Webb,et al. Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men. , 1999, Hypertension.
[39] Gnana Bharathy,et al. Vasopressin increases Na-K-2Cl cotransporter expression in thick ascending limb of Henle's loop. , 1999, American journal of physiology. Renal physiology.